Add to ORKGPump thrombosis is a serious complication of continuous-flow left ventricular assist devices (LVAD). Treatment options include medical thrombolysis, surgical pump exchange or urgent heart transplantation. We are reporting a case of pump thrombosis with active hemolysis and acute renal failure managed surgically by isolating the LVAD while awaiting renal recovery and donor heart availability
Renal failure after left ventricular assist device (LVAD) implantation occurs either due to worsenin...
AbstractThe left ventricular assist device (LVAD) is a battery-operated, mechanical pump-type device...
A 61-year-old woman who underwent HeartMate II left ventricular assist device placement for non-isch...
Pump thrombosis is a serious complication of continuous-flow left ventricular assist devices (LVAD)....
Over the past decade, left ventricular assist device (VAD) therapy has become more prevalent and inc...
End-stage heart failure is more often treated with Implantable left ventricular assist device (LVAD)...
Left ventricular assist device (LVAD) implantation is an established treatment for patients with end...
Thromboembolic events occur in 2–3 % of patients receiving the HeartMate II ™ (HMII) left ventricula...
Left ventricular assist device (LVAD) outflow graft injury is a very rare complication after LVAD im...
textabstractBackground Despite advances in pump technology, thromboembolic events/acute pump thrombo...
In patients with advanced heart failure (HF), left ventricular assist devices (LVADs) have demonstra...
Mechanical circulatory support (MCS) devices, such as left ventricular assist devices (LVADs) are ve...
Background Despite advances in pump technology, thromboembolic events/acute pump thrombosis remain p...
Copyright © 2012 Jens Garbade et al. This is an open access article distributed under the Creative C...
Left ventricular assist devices (LVADs), more importantly the continuous-flow subclass, have revolut...
Renal failure after left ventricular assist device (LVAD) implantation occurs either due to worsenin...
AbstractThe left ventricular assist device (LVAD) is a battery-operated, mechanical pump-type device...
A 61-year-old woman who underwent HeartMate II left ventricular assist device placement for non-isch...
Pump thrombosis is a serious complication of continuous-flow left ventricular assist devices (LVAD)....
Over the past decade, left ventricular assist device (VAD) therapy has become more prevalent and inc...
End-stage heart failure is more often treated with Implantable left ventricular assist device (LVAD)...
Left ventricular assist device (LVAD) implantation is an established treatment for patients with end...
Thromboembolic events occur in 2–3 % of patients receiving the HeartMate II ™ (HMII) left ventricula...
Left ventricular assist device (LVAD) outflow graft injury is a very rare complication after LVAD im...
textabstractBackground Despite advances in pump technology, thromboembolic events/acute pump thrombo...
In patients with advanced heart failure (HF), left ventricular assist devices (LVADs) have demonstra...
Mechanical circulatory support (MCS) devices, such as left ventricular assist devices (LVADs) are ve...
Background Despite advances in pump technology, thromboembolic events/acute pump thrombosis remain p...
Copyright © 2012 Jens Garbade et al. This is an open access article distributed under the Creative C...
Left ventricular assist devices (LVADs), more importantly the continuous-flow subclass, have revolut...
Renal failure after left ventricular assist device (LVAD) implantation occurs either due to worsenin...
AbstractThe left ventricular assist device (LVAD) is a battery-operated, mechanical pump-type device...
A 61-year-old woman who underwent HeartMate II left ventricular assist device placement for non-isch...